SCHEMBL3553703

SCHEMBL3553703

C=CCc1cc(C(=O)N2CC[C@@H]2C(=O)OC)cc(OC)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 3/20 0.42
PDK2 Q15119 2/20 0.41
ALDH1A1 P00352 4/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 2/20 0.39
MMP2 P08253 1/20 0.36
ANPEP P15144 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
PTPN1 P18031 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
RECQL P46063 1/20 0.35
CASP6 P55212 1/20 0.35
GFER P55789 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3553701 1.00 FKBP1A (0.42) FKBP1APDK2ALDH1A1GAAKDM4E
SCHEMBL3552619 0.90 FKBP1A (0.50) FKBP1APDK2ALDH1A1GAAPOLB
SCHEMBL3552618 0.90 FKBP1A (0.50) FKBP1APDK2ALDH1A1GAAPOLB
SCHEMBL3543344 0.90 ALDH1A1 (0.39) FKBP1AALDH1A1GAAKDM4EMEN1
SCHEMBL3543340 0.90 ALDH1A1 (0.39) FKBP1AALDH1A1GAAKDM4EMEN1
SCHEMBL3545453 0.88 PDK2 (0.44) FKBP1APDK2ALDH1A1KMT2AHPGD
SCHEMBL3545452 0.88 PDK2 (0.44) FKBP1APDK2ALDH1A1KMT2AHPGD
SCHEMBL3544530 0.87 FKBP1A (0.44) FKBP1APDK2ALDH1A1GAAKDM4E
SCHEMBL3544529 0.87 FKBP1A (0.44) FKBP1APDK2ALDH1A1GAAKDM4E
SCHEMBL3548221 0.85 FKBP1A (0.43) FKBP1APDK2ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691843-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2010-04-06 US disclosed
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity VICURON HOLDINGS LLC 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity AMDHD2, OGA, ENGASE FKBP1A 3069/4885PDK2 2445/4885ALDH1A1 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.